National performance on door-in to door-out time among patients transferred for primary percutaneous coronary

Jeph Herrin1, Lauren E Miller, Dima F Turkmani

  • 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Insights

Delays in treatment for heart attack patients requiring transfer are common. Door-in to door-out (DIDO) times rarely meet the recommended 30 minutes, impacting timely percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Healthcare Management

Background:

  • ST-segment elevation acute myocardial infarction (STEMI) patients often require inter-hospital transfer for percutaneous coronary intervention (PCI).
  • Delays in treatment are frequent for these transfer patients.
  • Recommended door-in to door-out (DIDO) time for PCI transfer is under 30 minutes.

Purpose of the Study:

  • To assess national performance in DIDO times for STEMI patients.
  • To identify patient and hospital factors associated with DIDO time variations.

Main Methods:

  • Analysis of national data from 1034 hospitals involving 13,776 STEMI patients.
  • Utilized a mixed-effects multivariable model to examine DIDO time determinants.
  • Included patient characteristics (age, sex, race, contraindications) and hospital characteristics (size, region, location, case volume).

Main Results:

  • Only 9.7% of patients met the 30-minute DIDO time benchmark.
  • 31.0% of patients experienced DIDO times exceeding 90 minutes.
  • Significant delays observed for women, African Americans, patients with contraindications to fibrinolysis, and those treated at rural hospitals.

Conclusions:

  • The recommended 30-minute DIDO time is infrequently achieved for STEMI patients needing inter-hospital transfer for PCI.
  • Factors such as patient demographics and hospital characteristics significantly influence transfer delays.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...